Literature DB >> 3729162

Pulmonary and serum isotypic antibody responses of mice to live and inactivated influenza virus.

E S Balkovic, H R Six.   

Abstract

Primary and secondary immunoglobulin class-specific antibody responses in serum and pulmonary lavage fluids of mice were studied after respiratory infection and intramuscular vaccination with influenza virus. Infection and vaccination with inactivated virus vaccine induced primary IgM and IgG antibody responses in the serum and pulmonary lavage fluids (PLF). Neither immunizing method induced detectable serum IgA antibodies, and only infection generated IgA antibodies in PLF. The major portion of antibodies in PLF was derived from serum, but local synthesis of IgG and IgA antibodies was detected after virus infection. Vaccination of infection-primed mice boosted the IgM and IgG antibody concentrations in serum and PLF but had no effect on IgA antibody concentrations. Nonlethal infection of vaccine-primed mice generated secondary IgM and IgG antibody responses in serum and PLF and an IgA antibody response in PLF. Again, most of the antibody detected in PLF was derived from serum, but low concentrations of IgA and IgG were synthesized locally after infection. Although mice immunized with inactivated vaccine lacked the capacity to synthesize IgA antibody, they were protected from severe pulmonary disease when challenged with lethal influenza virus. These data support the concept that serum IgG antibodies are sufficient for prevention of severe pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729162     DOI: 10.1164/arrd.1986.134.1.6

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  2 in total

1.  Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064.

Authors:  H Yasui; J Kiyoshima; T Hori; K Shida
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization.

Authors:  G T Pang; R L Clancy; S E O'Reilly; A W Cripps
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.